| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |